Loading
Latest filing published 27 Feb 2026 for Volitionrx Ltd.
Based on 12 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Guy Archibald Innes is a declared insider of Volitionrx Ltd (board member), with filings sourced from SEC (Form 4). The record holds 62 filings, for trades running from 25 March 2013 to 26 February 2026.
Every open-market trade on record is a purchase: 25 purchases worth €6.5B, and no sale. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 19 share grants and 5 option exercises.
The median purchase comes to €148k. Clusters matter here: 6 out of 10 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 12 purchases show a median change of -8.9%, with the price up in 42% of them. This is a record of the past, not a forecast.
On 27 February 2026 came the latest disclosure, a share grant in Volitionrx Ltd. The clock since the last published purchase (23 February 2023) now reads 1,339 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 56 declarations